欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli O45:K1 10 kDa chaperonin (groS) CSB-YP483534EOK
CSB-EP483534EOK
CSB-BP483534EOK
CSB-MP483534EOK
CSB-EP483534EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP483535EOK
CSB-EP483535EOK
CSB-BP483535EOK
CSB-MP483535EOK
CSB-EP483535EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Protein syd (syd) CSB-YP483536EOK
CSB-EP483536EOK
CSB-BP483536EOK
CSB-MP483536EOK
CSB-EP483536EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP483537EOK1
CSB-EP483537EOK1
CSB-BP483537EOK1
CSB-MP483537EOK1
CSB-EP483537EOK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 HTH-type transcriptional regulator UlaR (ulaR) CSB-YP483538EOK
CSB-EP483538EOK
CSB-BP483538EOK
CSB-MP483538EOK
CSB-EP483538EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 30S ribosomal protein S18 (rpsR) CSB-YP483539EOK
CSB-EP483539EOK
CSB-BP483539EOK
CSB-MP483539EOK
CSB-EP483539EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Aspartate carbamoyltransferase regulatory chain (pyrI) CSB-YP483540EOK
CSB-EP483540EOK
CSB-BP483540EOK
CSB-MP483540EOK
CSB-EP483540EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Zinc transport protein ZntB (zntB), partial CSB-YP483541EOK1
CSB-EP483541EOK1
CSB-BP483541EOK1
CSB-MP483541EOK1
CSB-EP483541EOK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 tRNA-modifying protein ygfZ (ygfZ) CSB-YP483542EOK
CSB-EP483542EOK
CSB-BP483542EOK
CSB-MP483542EOK
CSB-EP483542EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Ribose-5-phosphate isomerase A (rpiA) CSB-YP483543EOK
CSB-EP483543EOK
CSB-BP483543EOK
CSB-MP483543EOK
CSB-EP483543EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Trans-aconitate 2-methyltransferase (tam) CSB-YP483544EOK
CSB-EP483544EOK
CSB-BP483544EOK
CSB-MP483544EOK
CSB-EP483544EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Ribosomal RNA small subunit methyltransferase C (rsmC) CSB-YP483545EOK
CSB-EP483545EOK
CSB-BP483545EOK
CSB-MP483545EOK
CSB-EP483545EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Trp operon repressor (trpR) CSB-YP483546EOK
CSB-EP483546EOK
CSB-BP483546EOK
CSB-MP483546EOK
CSB-EP483546EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Isoleucine--tRNA ligase (ileS), partial CSB-YP483547EOP
CSB-EP483547EOP
CSB-BP483547EOP
CSB-MP483547EOP
CSB-EP483547EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Crotonobetainyl-CoA:carnitine CoA-transferase (caiB) CSB-YP483548EOP
CSB-EP483548EOP
CSB-BP483548EOP
CSB-MP483548EOP
CSB-EP483548EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Protein ApaG (apaG) CSB-YP483549EOP
CSB-EP483549EOP
CSB-BP483549EOP
CSB-MP483549EOP
CSB-EP483549EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 3-isopropylmalate dehydratase large subunit (leuC) CSB-YP483550EOP
CSB-EP483550EOP
CSB-BP483550EOP
CSB-MP483550EOP
CSB-EP483550EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC) CSB-YP483551EOP
CSB-EP483551EOP
CSB-BP483551EOP
CSB-MP483551EOP
CSB-EP483551EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Iron--sulfur cluster insertion protein ErpA (erpA) CSB-YP483552EOP
CSB-EP483552EOP
CSB-BP483552EOP
CSB-MP483552EOP
CSB-EP483552EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 UPF0253 protein yaeP (yaeP) CSB-YP483553EOP
CSB-EP483553EOP
CSB-BP483553EOP
CSB-MP483553EOP
CSB-EP483553EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×